Is Ginkgo Bioworks Stock a Good Buy?
Biotech innovator Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) has had better…
Buy
89
KRMN Quote, Financials, Valuation and Earnings
Last price:
$43.86
Seasonality move
:
--
Day range:
$43.50 - $45.20
52-week range:
$25.03 - $45.70
Dividend yield:
0%
P/E ratio:
1,594.07x
P/S ratio:
16.15x
P/B ratio:
16.79x
Volume:
502.7K
Avg. volume:
871.3K
1-year change:
--
Market cap:
$5.9B
Revenue:
$345.3M
EPS (TTM):
$0.03
Analysts' Opinion
-
Consensus RatingKarman Holdings has received a consensus rating of Buy. The company's average rating is a Buy based on 4 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $46.38, Karman Holdings has an estimated upside of 4.64% from its current price of $44.32.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $44.00 representing 100% downside risk from its current price of $44.32.
Fair Value
-
According to the consensus of 4 analysts, Karman Holdings has 4.64% upside to fair value with a price target of $46.38 per share.
KRMN vs. S&P 500
-
Over the past 5 trading days, Karman Holdings has overperformed the S&P 500 by 11.54% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Karman Holdings does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Karman Holdings has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Karman Holdings reported revenues of $100.1M.
Earnings Growth
-
Karman Holdings has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Karman Holdings reported earnings per share of -$0.04.
Enterprise value:
6.1B
EV / Invested capital:
8.92x
Price / LTM sales:
16.15x
EV / EBIT:
111.34x
EV / Revenue:
17.30x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-8,436.32x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
69.47x
Gross Profit (TTM):
$133.2M
Return On Assets:
0.47%
Net Income Margin (TTM):
1.06%
Return On Equity:
1.61%
Return On Invested Capital:
0.82%
Operating Margin:
9.95%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | -- | -- | $351.4M | $83M | $100.1M | |
| Gross Profit | -- | -- | $133.2M | $29M | $39.5M | |
| Operating Income | -- | -- | $51.8M | $13.5M | $10M | |
| EBITDA | -- | -- | $87.5M | $21.6M | $19.3M | |
| Diluted EPS | -- | -- | $0.03 | $0.02 | -$0.04 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | -- | -- | -- | $301.5M | |
| Total Assets | -- | -- | -- | -- | $875.4M | |
| Current Liabilities | -- | -- | -- | -- | $90.3M | |
| Total Liabilities | -- | -- | -- | -- | $526.5M | |
| Total Equity | -- | -- | -- | -- | $348.9M | |
| Total Debt | -- | -- | -- | -- | $332.6M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | $3.1M | -$13.6M | |
| Cash From Investing | -- | -- | -- | -$32.3M | -$11M | |
| Cash From Financing | -- | -- | -- | $31M | $126.8M | |
| Free Cash Flow | -- | -- | -$720.3K | $1.5M | -$18.6M | |
KRMN
Sector
Market Cap
$5.9B
--
Price % of 52-Week High
96.98%
--
Dividend Yield
0%
--
Shareholder Yield
-4.09%
--
1-Year Price Total Return
--
--
Beta (5-Year)
--
--
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
1%
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$41.67
200-day SMA
Buy
Level
$0.00
Bollinger Bands (100)
Buy
Level
0 - 0
Chaikin Money Flow
Buy
Level
14.1M
20-day SMA
Buy
Level
$38.33
Relative Strength Index (RSI14)
Buy
Level
75.65
ADX Line
Buy
Level
29.14
Williams %R
Sell
Level
-11.525
50-day SMA
Buy
Level
$35.11
MACD (12, 26)
Buy
Level
3.36
25-day Aroon Oscillator
Buy
Level
88
On Balance Volume
Neutral
Level
22.5M
Financial Scores
--
Altman Z-Score
(Annual)
Level (--)
Sell
CA Score
(Annual)
Level (-2.1835)
Buy
Beneish M-Score
(Annual)
Level (-2.5235)
--
Momentum Score
Level (--)
Sell
Ohlson Score
Level (1.6056)
Buy
Piotroski F Score
(Annual)
Level (7)
--
Quality Ratio Score
Level (--)
Buy
Fundamental Score
Level (5)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Karman Holdings Inc specializes in the upfront design, testing, manufacturing, and sale of mission-critical systems for existing and emerging missile and defense, and space programs. Its integrated payload protection, propulsion, and interstage system solutions are deployed across a wide variety of existing and emerging programs supporting important Department of Defense (DoD) and space sector initiatives. Its engineered solutions are organized into three key families: Payload Protection and Deployment Systems, Aerodynamic Interstage Systems, and Propulsion Systems. The company's solutions are deployed across three growing, core end markets: Hypersonics & Strategic Missile Defense, Missile & Integrated Defense Systems, and Space & Launch.
Stock Forecast FAQ
In the current month, KRMN has received 4 Buy ratings 0 Hold ratings, and 0 Sell ratings. The KRMN average analyst price target in the past 3 months is $46.38.
-
Where Will Karman Holdings Stock Be In 1 Year?
According to analysts, the consensus estimate is that Karman Holdings share price will rise to $46.38 per share over the next 12 months.
-
What Do Analysts Say About Karman Holdings?
Analysts are divided on their view about Karman Holdings share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Karman Holdings is a Sell and believe this share price will drop from its current level to $44.00.
-
What Is Karman Holdings's Price Target?
The price target for Karman Holdings over the next 1-year time period is forecast to be $46.38 according to 4 Wall Street analysts, 4 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is KRMN A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Karman Holdings is a Buy. 4 of 4 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of KRMN?
You can purchase shares of Karman Holdings via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Karman Holdings shares.
-
What Is The Karman Holdings Share Price Today?
Karman Holdings was last trading at $43.86 per share. This represents the most recent stock quote for Karman Holdings. Yesterday, Karman Holdings closed at $44.32 per share.
-
How To Buy Karman Holdings Stock Online?
In order to purchase Karman Holdings stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Mobileye Might Be Wall Street’s Next Big Surprise
The trend to automate vehicles started long ago when adding…
Why Is Rigetti Stock Going Up?
Quantum computing firm Rigetti Computing (NASDAQ:RGTI) has been one of…
Stock Ideas
Buy
70
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Buy
71
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
99
SOC alert for May 20
Sable Offshore [SOC] is down 0.79% over the past day.
Buy
52
RGC alert for May 20
Regencell Bioscience Holdings [RGC] is up 31.16% over the past day.
Sell
40
GWLIF alert for May 20
Great-West Lifeco [GWLIF] is up 13.42% over the past day.
